AB68-SSA1,2994 25Section 2994. 632.796 of the statutes is created to read:
AB68-SSA1,1353,2
1632.796 Drug cost report. (1) Definition. In this section, “disability
2insurance policy” has the meaning given in s. 632.895 (1) (a).
AB68-SSA1,1353,8 3(2) Report required. Annually, at the time the insurer files its rate request
4with the commissioner, each insurer that offers a disability insurance policy that
5covers prescription drugs shall submit to the commissioner a report that identifies
6the 25 prescription drugs that are the highest cost to the insurer and the 25
7prescription drugs that have the highest cost increases over the 12 months before the
8submission of the report.
AB68-SSA1,2995 9Section 2995. 632.862 of the statutes is created to read:
AB68-SSA1,1353,11 10632.862 Application of prescription drug payments. (1) Definitions. In
11this section:
AB68-SSA1,1353,1212 (a) “Brand name” has the meaning given in s. 450.12 (1) (a).
AB68-SSA1,1353,1313 (b) “Brand name drug” means any of the following:
AB68-SSA1,1353,1514 1. A prescription drug that contains a brand name and that has no generic
15equivalent.
AB68-SSA1,1353,1916 2. A prescription drug that contains a brand name and has a generic equivalent
17but for which the enrollee has received prior authorization from the insurer offering
18the disability insurance policy or the self-insured health plan or authorization from
19a physician to obtain the prescription drug under the policy or plan.
AB68-SSA1,1353,2020 (c) “Disability insurance policy” has the meaning given in s. 632.895 (1) (a).
AB68-SSA1,1353,2121 (d) “Prescription drug” has the meaning given in s. 450.01 (20)
AB68-SSA1,1353,2222 (e) “Self-insured health plan” has the meaning given in s. 632.85 (1) (c).
AB68-SSA1,1354,3 23(2) Application of discounts. A disability insurance policy that offers a
24prescription drug benefit or a self-insured health plan shall apply to any calculation
25of an out-of-pocket maximum and to any deductible of the policy or plan for an

1enrollee the amount that any discount provided by the manufacturer of a brand
2name drug reduces the cost sharing amount charged to an enrollee for that brand
3name drug.
AB68-SSA1,2996 4Section 2996. 632.863 of the statutes is created to read:
AB68-SSA1,1354,5 5632.863 Pharmaceutical representatives. (1) Definitions. In this section:
AB68-SSA1,1354,86 (a) “Health care professional” means a physician or other health care
7practitioner who is licensed to provide health care services or to prescribe
8pharmaceutical or biologic products.
AB68-SSA1,1354,109 (b) “Pharmaceutical” means a medication that may legally be dispensed only
10with a valid prescription from a health care professional.
AB68-SSA1,1354,1311 (c) “Pharmaceutical representative” means an individual who markets or
12promotes pharmaceuticals to health care professionals on behalf of a pharmaceutical
13manufacturer for compensation.
AB68-SSA1,1354,1714 (d) “Wholesale acquisition cost” means the most recently reported
15manufacturer list or catalog price for a brand-name drug or generic drug available
16to wholesalers or direct purchasers in the United States, before application of
17discounts, rebates, or reductions in price.
AB68-SSA1,1354,23 18(2) Licensure. (a) No individual may act as a pharmaceutical representative
19in this state without obtaining a pharmaceutical representative license. In order to
20obtain a license, an individual shall apply to the commissioner, on a form prescribed
21by the commissioner. A license issued under this paragraph shall be renewed on an
22annual basis. The application to obtain or renew a license shall include all of the
23following information:
AB68-SSA1,1354,2524 1. The applicant's full name, residence address and telephone number, and
25business address and telephone number.
AB68-SSA1,1355,1
12. A description of the type of work in which the applicant will engage.
AB68-SSA1,1355,22 3. The fee under s. 601.31 (1) (nv).
AB68-SSA1,1355,43 4. An attestation that the applicant meets the professional education
4requirements under sub. (3).
AB68-SSA1,1355,55 5. Proof that the applicant has paid any assessed penalties and fees.
AB68-SSA1,1355,66 6. Any other information required by the commissioner.
AB68-SSA1,1355,117 (b) The pharmaceutical representative shall report, in writing, to the
8commissioner any change to the information submitted on the application under par.
9(a) or any material change to the pharmaceutical representative's business
10operations or to any information provided under this section. The report shall be
11made no later than 4 business days after the change or material change occurs.
AB68-SSA1,1355,1312 (c) A pharmaceutical representative shall display his or her license during each
13visit with a health care professional.
AB68-SSA1,1355,18 14(3) Professional education requirements. (a) In order to become initially
15licensed under sub. (2) (a), a pharmaceutical representative shall complete a
16professional education course as determined by the commissioner. A pharmaceutical
17representative shall, upon request, provide the commissioner with proof of the
18coursework's completion.